Tom Amick

Health Technology

Finance

Profile

Prior to joining Quaker BioVentures' Advisory Board, Mr. Amick retired from a highly successful 30 year career with Johnson & Johnson.
After starting the biotechnology/oncology business within J&J, Mr. Amick advanced to the position of Vice President of the Oncology Franchise where he developed one of the most successful businesses in the history of J&J.
Mr. Amick held positions of increasing responsibility including, President of Janssen-Ortho, President of Ortho Biotech Europe, and Vice President of J&J Development Corporation.

Former positions of Tom Amick

Companies	Position	End
Quaker Partners Management LP Quaker Partners Management LP Investment ManagersFinance Quaker Partners Management LP (Quaker Partners Mgmt) is a venture capital subsidiary of Independence Capital Partners Inc founded in 2002 by Ira Mark Lubert and Paul Sherrill Neff. The firm is headquartered in Philadelphia, Pennsylvania.	Private Equity Investor	2010-03-29
Janssen, Inc. Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada.	Corporate Officer/Principal	-
JOHNSON & JOHNSON	Corporate Officer/Principal	-

See the detail of Tom Amick's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies